Package advice polatuzumab vedotin (Polivy®) in combination with bendamustine and rituximab (Pola-BR) for the treatment of r/r DLBCL
van der Waal JM, Wijma S
Record ID 32018001609
Dutch
Original Title:
Package advice polatuzumab vedotin (Polivy®
Details
Project Status:
Completed
Year Published:
2020
URL for published report:
https://english.zorginstituutnederland.nl/publications/reports/2020/12/10/polatuzumab-vedotin-polivy
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
The Netherlands
MeSH Terms
- Lymphoma, Large B-Cell, Diffuse
- Antibodies, Monoclonal
- Antineoplastic Combined Chemotherapy Protocols
- Immunoconjugates
- Bendamustine Hydrochloride
- Rituximab
Contact
Organisation Name:
The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address:
Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name:
Timon Sibma
Contact Email:
TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.